Tymora Analytical Operations

Tymora Analytical is a privately held US-based company founded in 2012, offering advanced proteomics services centered on its proprietary EVtrap platform for extracellular vesicle analysis. The company's technology enables the identification of over 1,000 unique proteins from minute volumes of plasma or urine, positioning it as a leader in non-invasive biomarker discovery. It primarily serves pharmaceutical companies, biotechs, CROs, and academic researchers as a contract service provider. Tymora's approach addresses the limitations of genetic screens and other liquid biopsy components by providing real-time, functional protein data from easily accessible biofluids.

EVtrap (Extracellular Vesicles Total Recovery and Purification) - a non-antibody affinity bead-based technology for isolating extracellular vesicles (exosomes) from biofluids, coupled with high-sensitivity LC-MS/MS for deep proteomic and phosphoproteomic analysis.

Tymora competes with other proteomics service CROs and academic core facilities. Its specific differentiator is its claimed superior sensitivity for EV proteomics from ultra-low volume biofluids. It also competes indirectly with other liquid biopsy modalities focusing on ctDNA or CTCs, arguing for the complementary, functional value of protein data from EVs.